A patient with diabetes is starting insulin therapy. Which type of insulin will the nurse discuss using for mealtime coverage.

Prochlorperazine is an antiemetic medication that is commonly used to treat nausea and vomiting caused by various conditions, including chemotherapy, radiation therapy, and surgery. Giving the medication before the dressing changes, can prevent or minimize the onset of nausea and vomiting, which can be triggered by the pain and anxiety associated with the procedure.

Option B, keeping the patient NPO (nothing by mouth) for 2 hours before dressing changes, may be helpful in reducing the risk of aspiration if the patient needs sedation or general anesthesia for the procedure. However, it is not directly related to reducing the patient's nausea.

Option C, avoiding performing dressing changes close to the patient's mealtimes, may help reduce the risk of nausea caused by an overly full stomach, but it is not directly related to reducing the patient's nausea during the procedure.

Option D, administering prescribed morphine sulfate before dressing changes, may help reduce the patient's pain during the procedure, but it may also increase the risk of nausea and vomiting as a side effect. Therefore, this option may not be the most useful in decreasing the patient's nausea.

Desmopressin acetate (DDAVP) is a synthetic hormone used to treat diabetes insipidus, which is a condition that causes excessive urination and thirst due to a lack of antidiuretic hormone (ADH) production in the body. By mimicking the effects of ADH, Desmopressin acetate (DDAVP) helps to reduce the amount of urine produced by the body and increase water reabsorption, which helps to alleviate symptoms of diabetes insipidus.

Therefore, the nurse should monitor the patient's urinary output and ensure that it decreases in response to the medication. It is important to note that Desmopressin acetate (DDAVP) can also cause hyponatremia (low sodium levels in the blood), so sodium levels should also be monitored during treatment.